Wisconsin is moving toward a future without viral hepatitis, launching a comprehensive statewide strategy designed to eliminate the disease by 2030. The Wisconsin Department of Health Services (DHS) announced the initiative alongside a new public-facing dashboard, a tool intended to provide transparency and real-time tracking of the state’s progress in testing, vaccination and treatment.
The Wisconsin viral hepatitis elimination plan aligns with the broader CDC Viral Hepatitis National Strategic Plan, focusing on reducing the incidence of hepatitis A, B, and C to prevent the long-term complications of liver disease. By coordinating efforts between community-based organizations, healthcare providers, and local and Tribal health departments, the state aims to close gaps in care for populations that have historically been disproportionately affected by these infections.
For many residents, the danger of viral hepatitis lies in its invisibility. These infections often progress without symptoms for years, leaving patients unaware of their status until the virus has caused significant damage. According to the DHS, the only definitive way to identify an infection is through targeted testing, which the new plan seeks to make more accessible across the state.
State Health Officer Paula Tran emphasized that the goal is achievable because the medical tools already exist. “We are proud to launch this statewide plan to eliminate viral hepatitis by 2030. This plan will guide our efforts to make hepatitis A, B, and C testing, vaccination, and treatment more accessible, especially for the Wisconsin residents most at risk,” Tran said. “With preventative vaccines available for hepatitis A and B and curative treatment available for hepatitis C, viral hepatitis elimination is possible in Wisconsin.”
A Data-Driven Approach to Public Health
Central to the state’s strategy is the launch of a public health dashboard. Rather than relying on static reports, the DHS will use this tool to analyze and display data from the Wisconsin Immunization Registry (WIR), Wisconsin Vital Records, and other public health disease datasets. The dashboard will be updated annually, allowing health officials and the public to see exactly where the state stands in relation to its 2030 goals.
This shift toward open data is intended to help providers and community leaders identify “hot spots” or underserved regions where testing and vaccination rates are lagging. By identifying these gaps, the DHS can better allocate resources and develop new partnerships to reach high-risk populations.
The urgency of the plan is underscored by the scale of the problem. While the CDC estimates that nearly four million Americans are living with chronic hepatitis C, the impact in Wisconsin is significant, with an estimated 47,000 residents currently living with the chronic form of the virus.
Understanding the Three Primary Strains
From a clinical perspective, it is important to distinguish between the three main types of viral hepatitis, as their transmission routes and prevention methods differ fundamentally. While all three target the liver and can lead to cirrhosis or liver cancer, the medical response for each is distinct.
Hepatitis A is primarily an acute infection often spread through contaminated food or water, or via contact with an infected person. It does not become chronic but can cause severe short-term illness. In contrast, Hepatitis B and C are blood-borne pathogens, transmitted through blood-to-blood contact. These two strains are more likely to become chronic, long-term infections that silently erode liver function over decades.
| Hepatitis Type | Primary Transmission | Prevention/Treatment | Chronic Potential |
|---|---|---|---|
| Hepatitis A | Contaminated food/water | Vaccine available | No |
| Hepatitis B | Blood-to-blood contact | Vaccine available | Yes |
| Hepatitis C | Blood-to-blood contact | Curative medication (8-12 weeks) | Yes |
One of the most significant advancements in liver health over the last decade has been the development of direct-acting antivirals for Hepatitis C. Unlike Hepatitis A and B, there is no vaccine for Hepatitis C, but the disease is now highly curable. Most patients can be completely cleared of the virus with a course of medication lasting between eight and 12 weeks.
Clinical Guidance for Wisconsinites
To support the 2030 elimination goal, health officials are urging residents to take proactive steps in screening and prevention. Because the disease is often asymptomatic in its early stages, waiting for symptoms to appear usually means the disease has already progressed to a more serious stage.
Medical guidelines now recommend that every adult aged 18 and older be tested for hepatitis B and C at least once in their lifetime. For those who are pregnant, the recommendation is more frequent; testing for both B and C is advised during every pregnancy to prevent mother-to-child transmission and ensure early intervention for the parent.
Residents are encouraged to discuss their vaccination status for hepatitis A and B with their primary care providers. These vaccines provide long-term protection and are the first line of defense in preventing the onset of chronic liver disease.
For those seeking more information or wishing to view the state’s progress, the Wisconsin Department of Health Services has hosted the full Elimination Plan and the tracking dashboard on its official viral hepatitis webpage.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Please consult a licensed healthcare provider for diagnosis, treatment, and vaccination schedules tailored to your specific health needs.
The DHS will continue to monitor the effectiveness of the elimination plan through its annual dashboard updates, with the first full year of data analysis expected to provide a baseline for the state’s trajectory toward the 2030 deadline.
Do you have questions about liver health or the new state guidelines? Share this article and join the conversation in the comments below.
